ALOXE3 and metastatic malignant neoplasm in the lymph nodes: The positive rate of ALOXE3 expression in tumor samples with positive lymph node metastasis (78.3%) was significantly higher than that in those without lymph node metastasis (60.3%) (P < 0.05).